From “Trump” to “Russian” to “dentist,” the only way to gaze into the Epstein-files abyss is through a keyword-size hole.

Competing with giants like Takeda and Moderna, the plucky biotech believes it has unlocked a future with an easy, yearly oral vaccine.

Patrick Healy, an assistant managing editor who oversees The Times’s journalistic standards, talked with four of the journalists who are working on the Epstein files to kick around those questions.

The Epstein files story has taken on the dimensions of a labyrinthine dark thriller, one that promises a revelation at the end of the tunnel.

Two dozen journalists. A pile of pages that would reach the top of the Empire State Building. And an effort to find the next ...

Moderna Inc (NASDAQ:MRNA, XETRA:0QF) shares fell almost 6% after the drugmaker announced that the US Food and Drug ...

FDA refuses Moderna's mRNA flu vaccine application, citing inadequate study design, as the company disputes decision, saying it contradicts prior FDA guidance.

Refusal to review the submission is inconsistent with feedback at pre-Phase 3 and pre-submission consultations; Moderna has requested a Type A meeting to understand the path forwardmRNA-1010 has been ...

Poland’s Prime Minister Donald Tusk has announced the launch of an inquiry into possible Polish links to a sex trafficking scandal involving the late US financier Jeffrey Epstein. Poland's Prime ...

The Trump administration may have shuttered Direct File — the IRS’s short-lived experiment in tax-preparation software — but it doesn’t mean you have to pay to file your taxes. There are plenty of ...

Got your W-2s ready? Today, the IRS will begin accepting 2025 tax returns for the 2026 tax filing season. “The Internal Revenue Service is ready to help taxpayers meet their tax filing and payment ...